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ABSTRACT: In this article, pH-responsive near-infrared emitting
conjugated polymer nanoparticles (CPNs) are prepared, charac-
terized, and their stabilities are investigated under various con-
ditions. These nanoparticles have capacity to be loaded with
water insoluble, anticancer drug, camptothecin (CPT), with
around 10% drug loading efficiency. The in vitro release stud-
ies demonstrate that the release of CPTs from CPNs is pH-
dependent such that significantly faster drug release at mildly
acidic pH of 5.0 compared with physiological pH 7.4 is
observed. Time and dose-dependent in vitro cytotoxicity tests
of blank and CPT-loaded nanoparticles are performed by real-
time cell electronic sensing (RT-CES) assay with hepatocellular
carcinoma cells (Huh7). The results indicate that CPNs can be
effectively utilized as vehicles for pH-triggered release of anti-
cancer drugs. VC 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part
A: Polym. Chem. 2015, 53, 114–122
KEYWORDS: cellular imaging; conjugated polymers; drug
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INTRODUCTION The delivery of drugs by nanoparticle-based
systems offers many advantages over conventional methods
such as reduced systemic toxicity and enhanced drug effi-
ciency on target could be achieved due to enhanced permea-
tion and retention effect (EPR).1–3 Moreover, these systems
can be designed to include multiple moieties such as active
site targeting agents, imaging agents, immune evasion mech-
anisms, and microenvironment sensors for passive targeting
at the cost of increased complexity and convoluted working
mechanisms with each added moiety.4 Especially, polymeric
nanoparticles are very appropriate for this purpose as their
versatile surface chemistry can easily be adjusted for func-
tionalizing with different moieties.5–7 Furthermore, their
sizes can be tuned for different applications by changing
simple parameters in the synthesis procedure. Most poly-
mers tend to be biocompatible and show low toxicity due to
their chemical inertness or they can be designed to degrade
into harmless compounds in biological media. In addition,
the microenvironment sensing properties such as pH sensi-
tivity can be added to these polymers by making simple
changes in the polymer structure.8–11 It is known from the
literature that endosomes and tumour microenvironments
have relatively acidic pH values. Once the drug-loaded
nanoparticles are internalized by the cells, some of the endo-
cytosed drug-loaded nanoparticles begin to hydrolyse under
acidic environment in endosomes; this will, in turn, causes
the swelling of nanoparticles and simultaneous delivery of
drugs into the cytosol.12
Real-time biological imaging of the tumour site is one of the
most important factors in cancer treatment.13,14 Moreover,
combining therapeutic and imaging agents on a single sys-
tem provides information about drug biodistribution and
pathological processes which helps physicians to make more
informed decisions on treatment strategies. To this end,
there has been great interest to develop multifunctional
nanoparticles which contain fluorescence imaging agents.15
For this purpose, small fluorescent dyes and fluorescent pro-
teins are used as traditional fluorescent markers but they
exhibit poor photostability as they fade away rapidly during
imaging and this, in turn, limits their use in long term moni-
toring of live cells.16 Luminescent nanoparticles such as
quantum dots and dye-loaded silica nanoparticles are found
to be suitable for these purposes as these nanoparticles pos-
sess high brightness and photostability compared with small
fluorescent dyes. However, their cytotoxicity is considered as
a serious problem for their in vivo applications because of
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the presence of toxic heavy metals (e.g. Cd).17 Dye-loaded
silica nanoparticles also present some drawbacks; only lim-
ited amount of dyes can be loaded due to p-p interaction
between the dye molecules which causes a reduced fluores-
cent quantum yields.18
An emerging alternative is the use of conjugated polymer
particles as fluorescent labels because of their high quantum
yields, high molar absorptivity, photo stability, and easy syn-
thesis.19–31 However, there is not much research on the met-
abolic processes of these nanoparticles. In the in vivo
studies, the biodistribution profile of these nanoparticles
after 72 h postinjection showed uptake in the tumorous tis-
sue as well as liver and the spleen indicating that they could
be cleared out from the body through liver.32 Although the
use of conjugated polymer nanoparticles for dual delivery of
therapeutic agents and cell imaging offers many advantages,
this strategy is largely unexplored and there are few reports
relating to this concept.33–38 For instance, the inherent fluo-
rescence of the conjugated polymers could eliminate the
need for an imaging agent in the designed delivery vehicle
thus making the system less complicated. There are many
examples in the literature on the pH-responsive polymeric
nanoparticles designed for the delivery of drugs;8,9,39 how-
ever, to the best of our knowledge, examples are scarce on
the drug delivery system which is based on pH-responsive
near-infrared emitting conjugated polymer nanoparticles.
Recently we have reported on the red emitting pH-
responsive conjugated oligomer-based nanoparticles for drug
delivery and cellular imaging.40 Although these conjugated
oligomer-based nanoparticles have many interesting features,
they emit in the far red region and exhibit relatively low
drug-loading efficiency (5.9%) which needs further improve-
ment. In this context, we report here novel, pH-responsive,
near-infrared emitting conjugated polymer nanoparticles
with higher drug loading efficiency than oligomer-based
nanoparticles for cellular imaging and controlled-drug
release. These nanoparticles emit in the near-infrared region;
have good photostability and low toxicity that are essentials
for biological imaging. Near-infrared emission is highly desir-
able for bioimaging because it will enable high contrast in
vivo imaging due to the lack of interference from tissue auto-
fluorescence in the NIR window.41–43 In addition, due to the
pH-sensitive pendant groups on the polymer chains, nano-
particles formed from these polymers are sensitive to lower
pH levels found in most tumour microenvironments offering
a promise for use in chemotherapeutic drug delivery
applications.
EXPERIMENTAL
General
All solvents and reagents including, 2-(thiophen-3-yl)ethanol,
2,1,3-benzothiadiazole-4,7-bis(boronic acid pinacol ester), N-
bromosuccinimide, tetrabutylammonium bromide, bromo-
benzene, tetrakis(triphenylphosphine)palladium, were pur-
chased from Sigma-Aldrich Chemical Co. and were used as
received. 1H and 13C NMR spectra recorded on a Bruker
Avance III 400 MHz spectrometer using CDCl3 as a solvent.
FT-IR measurements recorded on a Bruker TENSOR 27. Sam-
ples were prepared as a KBr pellet. For optical characteriza-
tion, a UV–Vis spectrophotometer (Cary UV–Vis) and a
fluorescence spectrophotometer (Cary Eclipse Fluorescent
spectrophotometer) equipped with a xenon-lamp as the exci-
tation source were used. The molecular weight of the poly-
mer P1 was determined using gel permeation
chromatography (GPC) on Polymer Laboratories PL-GPC220
system equipped with a RI detector in THF using a calibra-
tion curve of polystyrene standards.
Nanoparticles sizes were measured by dynamic light scatter-
ing (DLS, Zetasizer Nano-ZS). Measurements were carried
out at 633 nm and the laser, as a light source, was used at
room temperature. Morphological characterization was done
by scanning electron microscopy (SEM, Quanta 200 FEG
SEM) and transmission electron microscopy (TEM, FEI Tec-
nai G2 F30). The DLS measurements were usually repeated
at least three times and the average values were reported.
2-(2,5-Dibromothiophen-3-yl)ethyl acetate (M2)
2-(2,5-dibromothiophen-3-yl)ethanol (M1) was synthesized
according to literature procedure.22 A stirred solution of M1
(1.00 g, 3.50 mmol) in 10 mL acetic anhydride was added
pyridine (400 mL, 5.24 mmol,) and the reaction mixture was
allowed to stir at room temperature for overnight. After the
reaction was over, the mixture was diluted with DCM; water
was added and the extraction was carried out. Organic phase
was collected and washed with water several times. The sol-
vent was evaporated under reduced pressure which pro-
vided pale yellow liquid. This was further stirred with
20 mL MeOH for 20 min to convert the remaining acid-
anhydride into methylester which was easily evaporated
under reduced pressure. Product was purified by Si-gel col-
umn chromatography using cyclohexane as an eluent (1.04 g,
90%).
1H-NMR (400 MHz, CDCl3, 25 C): d 6.85 (s, 1H, c), 4.25 (t,
3J5 6.4 Hz, 2H, a), 2.82 (t, 3J5 6.4 Hz, 2H, b), 2.05 (s, 3H, d);
13C-NMR (100 MHz, CDCl3, 25 C): d 20.9, 28.9, 62.9, 109.7,
110.9, 131.0, 138.3, 170.7. HRMS (ESI) calcd. for [M1K-2H]2
(C8H6Br2KO2S) 362.8087, found 362.8006.
Synthesis of Poly [2-(2,5-dibromo-thiophen-3-yl)-ethyl
acetate)-co-4,7-(2,1,3-benzothiadiazole)] (P1)
2-(2,5-dibromo-thiophen-3-yl)-ethyl acetate (515.4 mg, 1.581
mmol) and 2,1,3-benzothiadiazole-4,7-bis(boronic acid pina-
col ester) (613.9 mg, 1.581 mmol) were placed into a two-
necked RBF. The mixture was left under vacuum for 20 min.
Degassed THF (20 mL) was added and stirred for 10 min.
Then the aqueous solution of K2CO3 (1500 mg, 7.905 mmol)
in 10 mL degassed water was added, TBAB (50 mg) was
added and the reaction was stirred for 10 min. Then the
mixture was degassed via two cycles of freeze-pump-thaw
and the flask was filled with N2 gas. Pd(PPh3)4 (91 mg,
0.079 mmol) was added quickly. The mixture was heated to
80 C under N2 gas 16 h. Twenty milliliters degassed THF
and 10 mL degassed toluene were added. The mixture was
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further stirred under N2. A purple colour solution was
obtained. After about 66 h bromobenzene (100 mL) was
added and the reaction was further heated 4 h more. After
the completion of the reaction, the solvents were removed
under reduced pressure and the residue was washed with
water several times. Then the precipitate was filtered,
washed with MeOH. The crude product was redissolved in
THF and precipitated into cold MeOH for further purification.
Purple coloured powder was collected and dried under vac-
uum for 5 h (525 mg, 46%).
1H-NMR (400 MHz, CDCl3, 25 C): d: 2.05 (m, 3H), 3.15 (m,
2H), 4.4 (m, 2H), 7.1 (m, 1H), 7.9–8.2 (m, 2H); 13C-NMR
(100 MHz, CDCl3, 25 C): d 21.0, 29.1, 29.9, 64.2, 125.2,
125.6, 130.1, 130.4, 152.3, 152.6, 170.9.
GPC: Mn5 2.5 3 10
4 g mol21, Mw5 5.23 10
4 g mol21 (THF
as a solvent and polystyrene as standard).
Preparation of Nanoparticles of P1
In a typical procedure, P1 (1.0 mg, 3.3 3 1023 mmol, based
on per repeating unit) was dissolved in dry THF (1 mL). The
solution was sonicated for 15 min and then injected rap-
idly to 20 mL of DD water. The sonication was continued for
a further 30 min. THF was removed from the solution under
reduced pressure.
RESULTS AND DISCUSSION
Synthesis and Characterization of Polymer P1
For the preparation of pH-responsive and near-infrared emit-
ting nanoparticles, polymer 1 (Scheme 2) (P1) was designed
by taking the following points into consideration: P1 is
hydrophobic at neutral pH but can be made hydrophilic at
low and high pH values by hydrolysing the acetyl groups to
hydrophilic hydroxyl groups. Thus, it would be easier to
form nanoparticles and drug-loaded nanoparticles from
hydrophobic polymer P1; since the nanoparticles will have
more compact shapes at neutral pH and hold the drugs
tightly but at low or high pH values due to hydrolysis, the
nanoparticles will swell and the polymer chains will be
loosely folded because of the interaction of hydroxyl groups
with water. This, in turn, will trigger the release of drugs
from the nanoparticles (Scheme 1). Besides, P1 itself is self-
luminescent and emits in the near infrared region of the
spectrum.
This feature offers several advantages such as eliminating
the need for an extra fluorophore in the system for cellular
imaging and the drugs will be encapsulated in high loading
rate because of the favourable interactions with polymer aro-
matic backbone.
Polymer 1 was synthesized according to the reaction Scheme
2. First 2-(thiophen-3-yl)ethanol was brominated using N-
bromosuccinimide in ethyl acetate to obtain 2-(2,5-dibromo-
thiophen-3-yl)ethanol18d (M1) and then its hydroxyl group
was acetylated using acetic acid anhydride to yield the target
monomer (M2). Suzuki Coupling of M2 and 1,2,3-benzothia-
diazole-4,7-bis(boronic acid pinocol ester) afforded polymer
P1 in 46% yield as purple powders.
Structural characterization of polymer was carried out via
1H and 13C NMR (Supporting Information Fig. S3) and FT-IR
SCHEME 1 An overview of the preparation of drug-loaded nanoparticles and pH-triggered drug release mechanism of the nano-
particles. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
SCHEME 2 Reaction scheme for P1. (a) 2-(thiophen-3-yl)ethanol, NBS, EtOAc, 25 C, 12 h, 60%; (b) acetic anhydride, pyridine, 25
C, 12 h, 90%; (c) THF/toluene/H2O (1:1:1, v/v), K2CO3 (aq.), TBAB, Pd(PPh3)4, 80 C, 72 h, 46%.
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spectroscopies. Figure 1 show the 1H-NMR spectrum of P1
which confirms the expected structures of the polymer. In
the FT-IR spectrum of P1 (Supporting Information Fig. S5),
the presence of the characteristic carbonyl stretching at
around 1700 cm21 supports further the expected structure
of the polymer.
The molecular weight of polymer was determined by GPC
(Supporting Information Fig. S6). Mn and Mw values of P1
have been found to be as 25 kDa and 52 kDa, respectively,
with polydispersity index (PDI) of 2.1 which is in an
expected range for a step-growth polymerization.
Synthesis of Nanoparticles and Investigation of their
Stabilities
Nanoparticles were prepared by a simple reprecipitation
method as reported in the literature.37 Briefly, polymer solu-
tion in THF is injected into a large excess of water under
sonication and by the removal of the THF under reduced
pressure, stable nanoparticles are obtained. It is possible to
tune the sizes of nanoparticles by varying the concentration
of polymers used. Here we used different concentrations of
polymer to demonstrate the effect of polymer concentrations
on the nanoparticle sizes. The results confirm that the struc-
tures and the concentrations of the polymers directly affect
the size of nanoparticles; an increase in the polymer concen-
tration causes an increase in the size of the nanoparticles.
All details involving the synthesis of the nanoparticle with
varying concentration were provided in the Supporting Infor-
mation section (Supporting Information Tables S1 and S2,
Figs. S7 and S8). Nanoparticles with average size 56 nm have
been selected to be used throughout of this article with the
final polymer concentration of 0.5 mg/mL (in water). Figure 2
shows SEM (a), TEM (b) microscope images and DLS (c), zeta
potential (d) histograms of NP-P1 with average size 56 nm.
In order to test the stability of P1NPs in water and PBS
buffer (at pH 7.4), DLS measurements were taken over 35
days. The measurement results clearly show that there are
no significant changes in the initial size of the nanoparticles
confirming that these nanoparticles are stable in water and
PBS buffer for prolonged time (Supporting Information
Fig. S9).
FIGURE 1 1H-NMR (400 MHz, CDCl3, 25
C) spectrum of P1.
FIGURE 2 SEM (a), TEM (b) microscope images and DLS, zeta potential histograms of NP-P1. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
FIGURE 3 The nanoparticles in different protein environments
such as bovine serum albumin (BSA), human serum, and milk
to test their stabilities. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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Next, we incubated P1NPs in different protein environments
such as bovine serum albumin (BSA), milk, and human
serum to test their stabilities. The changes in the size of
nanoparticles are insignificant in both BSA and milk media
(Fig. 3). But there is around 10 nm increase in the incuba-
tion with human serum. This may be due to weak nonspe-
cific interactions of nanoparticles with some of the proteins
in the mixture.
The nanoparticles were further exposed to buffered aqueous
solutions of pH 5.0 or 8.0 and their average sizes and zeta
potential values were recorded at regular intervals (Support-
ing Information Figs. S10–S12). The size of the nanoparticles
exposed to pH 5.0, was gradually increased from the initial
size of 56 nm to 180 nm around 4 h and not much change
was observed even after 24 h. The initial zeta potential value
of 223 changed to 218 mV. SEM image of the nanoparticles
showed the presence of spherical nanoparticles with about
180 nm average size (Fig. 4). Similar results were obtained
with nanoparticles exposed to pH 8; however, in this case
the initial size of nanoparticles increased from 56 nm to
over 200 nm even in 1 h with zeta potential value of 224
(Supporting Information Fig. S12).
Although P1 is not a conventional pH-sensitive polymer
which contain carboxylic or amine groups, still the size
changes in the nanoparticles can be explained by the pH
responsiveness of the polymer 1. P1 contains acetyl groups
which can be hydrolyzed by acid or base. Consequently, the
nature of the polymer could be switched from hydrophobic
to hydrophilic by hydrolyzing acetyl group to hydroxyl group.
In this way, nanoparticles made from acetyl group carrying
polymer will exhibit hydrophobic character and have a
rather compact shape, however, by the hydrolysis of acetyl
groups to hydroxyl groups polymer chains will be loosely
held because of the interaction of hydroxyl groups with
water and the nanoparticles become larger.
Similar approach was reported by Griset et al.44,45 In their
work, first hydroxyl groups of the polymer used were pro-
tected as acetal to obtain a hydrophobic polymer which was
utilized to prepare cross-linked nanoparticles. When these
nanoparticles were exposed to pH 5, acetal groups were
hydrolyzed to reveal hydroxyl groups and because of the
interaction of hydroxyl groups with water the nanoparticles
expanded 3 to 10 folds of their initial size. Although in our
case the nanoparticles were not cross-linked, still they were
not completely disintegrated into polymer chains after the
hydrolysis due to the presence of a large hydrophobic poly-
mer backbone which helps keeping them intact.
The faster size increase in shorter duration at pH 8, com-
pared with pH 5 indicates that acetyl groups are hydrolyzed
faster at pH 8 than pH 5. To prove further hydrolysis is
FIGURE 4 SEM images of NP-P1, (a) initial state (scale 1 mm), (b) after 4 h exposure of pH 5 (scale 1 mm), (c) after 4 h exposure of
pH 5 (scale 2 mm), (d) DLS, zeta potential histograms of NP-P1 after 4 h exposure of pH 5. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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taking place, pH 5 and pH 8 treated nanoparticle dispersions
were centrifuged to obtain precipitate which was redis-
persed in water and centrifugation was repeated to remove
buffer residues. The collected precipitate was characterized
by FT-IR spectrometer. FT-IR spectra of both samples show
that the peak around 1700 cm21 due to the carbonyl
stretching of acetyl groups has disappeared indicating the
hydrolysis of acetyl groups (Supporting Information Fig.
S13).
Optical Properties of Polymer P1 and Nanoparticles
The optical properties of the nanoparticles were investigated
by UV-Vis and fluorescence spectroscopy and compared with
the polymers in different solvents and film; the results are
tabulated in the Table 1.
Bathochromic shifts were observed in the absorption and
emission spectra of the polymer P1 upon increasing the
polarity of solvent (Supporting Information, Fig. S14) imply-
ing that the polymer has solvatochromic properties.46 How-
ever, upon converting the polymer into nanoparticles larger
bathochromic shifts are observed in the emission peaks
which show similarities with the absorption and emission
spectra of the polymer in film (the spectrum is provided in
Supporting Information, Fig. S15). This suggests that the
bathochromic shifts are not only due to solvent effect but
also due to the intra and intermolecular interactions of poly-
mer chains caused by tight folding.
Drug Loading Study of Polymer Nanoparticles
Camptothecin-loaded nanoparticles have been prepared in a sin-
gle step synthesis. Briefly, polymers and CPT are dissolved in
THF and injected into water while stirring under sonication.
After the removal of THF, the dispersion of nanoparticles in
water is obtained. In order to determine the loading and entrap-
ment efficiency of the nanoparticles, ratios of CPT to polymers
(w/w) 1:0.5, 1:1, 1:2, 1:6.25, 1:12.5, and 1:25 were used during
the nanoparticle preparation. In each case, after the nanoparticle
formation, the dispersion was dialyzed against water using a 14
kDa MWCO regenerated cellulose membrane for 24 h to remove
any remaining unencapsulated CPT. The dialysates were ana-
lyzed by recording their absorption spectra (kmax5 366 nm)
and the unencapsulated CPT concentration was calculated from
a calibration curve of CPT plotted from known concentrations
of CPT solutions. The lowest detectable concentration in water
was 25.4 nM which shows that our method allows us to detect
less than 8% of CPT in the set with the lowest CPT concentra-
tion. The measurements taken from the dialysate of free CPT
showed the same absorbance with the corresponding concentra-
tion of CPT suspension in water containing Tween 20 (0.2%, v/
v) 24 h later. This shows that a 24 h-period is long enough for
unentrapped CPT to homogenously disperse into medium. The
entrapment efficiency (EE) and loading efficiency (LE) were cal-
culated according to the following equations and the results are
presented in Figure 5.
EE5 loaded drug wt./total drug wt. 3 100
LE5 loaded drug wt./total system wt. 3100
The set with the lowest CPT concentration (drug:polymer
ratio of 1:25) shows a 40% entrapment rate with the loading
efficiency of 1.6%. As CPT concentration increases, loading
efficiency increases up to around 9.8% and entrapment effi-
ciency reaches a plateau value of 63% at the drug to poly-
mer ratio of 1:6.25.
The synthesis of CPT-loaded CPNs was repeated more than
three times by keeping the synthetic conditions constant.
Their size was determined by dynamic light scattering (DLS)
measurements and the results are tabulated in the Support-
ing Information Table S5. As it can be seen from the DLS
measurements, the size of the drug loaded nanoparticles are
dependent on the drug loading contents as there is a linear
increase in the size of nanoparticles with increasing drug
contents. However, the changes are not huge indicating that
the structural integrity of the nanoparticles is not affected
when they are loaded with drug. The reason could also be
attributed to the p-p interactions between the aromatic con-
jugated backbone of the polymer chains and the aromatic
rings of the CPT molecules, causing a close packing of the
drug molecules.37
TABLE 1 Optical Properties of Polymer in Different Solvents,
Dispersion of Polymer Nanoparticles in Water, in Acetate
Buffer (pH 5.0), and Polymer Film
Solvent kabs (nm) kem (nm) Uf
a (%) eb (cm21 M21)
Chloroform 505 620 47.4 25,878
THF 510 627 31.9 21,813
DMF 515 640, 700 (sh) 17.3 12,119
Water 530 717 2.3 6902
Acetate buffer 530 717 3.0 7243
In film 544 731 n.d. n.d.
a Fluorescent quantum yields are calculated using Rhodamine B in etha-
nol as standard (Uf: 98%).
b Molar absorptivity per repeat unit.
n.d.: not determined; sh: shoulder.
FIGURE 5 Drug loading and entrapment efficiencies. [Color fig-
ure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG ARTICLE
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2015, 53, 114–122 119
In Vitro Drug Release Study of Nanoparticles
The in vitro drug release studies of the nanoparticles with
two different CPT contents as the CPT to P1NP ratios of 1:23
and 1:10 (determined after dialysis) were carried out at 37
C at pH 5.0 (acetate buffer) and pH 7.4 (PBS). The time-
dependent release profiles of CPT from the nanoparticles
were measured by the absorption at 366 nm with UV-Vis
spectrophotometry. Figure 6 shows the release profile of CPT
loaded P1NPs (CPT to P1NP ratio of 1:10).
In the case of nanoparticles with high drug loading content,
around 50% of drugs were released from P1NPs at pH 5.0
in the initial 12 h, and the release was sustained over 110 h,
however, 90% of drugs have already released during 64 h.
On the other hand, the release was slower in pH 7.4 com-
pared with pH 5.0. Only 50% of the drugs were released
around 48 h and 90% drug release reached to 256 h. The
release of drugs from nanoparticles with low drug loading
content was observed to be slightly faster at both pHs than
the former case (Supporting Information Fig. S18); the rea-
son could be due to p-p intermolecular interactions between
the CPT molecules in high loading of nanoparticles which
prevents the release of drugs.
The in vitro release studies demonstrated that the release of
CPTs from NP1 were pH-dependent such that significantly
faster drug release at mildly acidic pH of 5.0 (90% during
64 h) compared with physiological pH 7.4 (90% during 256
h) was observed. The above results indicated NP1 are appro-
priate vehicles for pH-triggered release of anticancer drugs.
In Vitro Cell Assays
Time and dose dependent in vitro cytotoxicity tests of blank
and CPT-loaded nanoparticles (P1NPs) were performed by
real-time cell electronic sensing (RT-CES)47,48 assay with
hepatocellular carcinoma cells (Huh7) over the course of
144 h. RT-CES experiments involve using a gold plate and
the system relies on electrical impedance cell sensors arrays
embedded at the bottom of the plates. In this experiment we
have tested the cytotoxicities of P1NPs as well as CPT-loaded
nanoparticles in two different drug loading contents. These
nanoparticles were abbreviated as P1NP-A-CPT and P1NP-B-
CPT which denote 1:62 and 1:10.4 (after dialysis), CPT/NP
ratios, respectively. Free CPT was used as a positive control
and DMSO and blank P1NPs were used as negative controls
to the CPT-loaded P1NPs. Figure 7 shows the RT-CES assay
results after the incubation of Huh7 cells with CPT, P1NPs
blank, P1NP-A-CPT and P1NP-B-CPT over 144 h incubation
period. Full experimental results were given in the Support-
ing Information Figure S17 and Table S6.
Blank nanoparticles at high concentrations (24.8 and 12.8 mM)
appear to cause some changes in the cell behavior after 24 h
incubation, growth inhibition reach to plateau values of 38 and
20%, for the nanoparticle concentrations of 24.8 and 12.8 mM,
respectively, at 72 h and then the inhibition rate decreases rap-
idly and the cells starts to be responsive again and proliferate.
This behavior may suggest the complex, dynamic nature of the
interaction between the cells and nanoparticles. This could
also be explained by an incidental enzyme interaction in which
the NPs could randomly bind on some proteins to inhibit their
activities, however, the cell signaling pathways get involved at
this stage by increasing the expression of proteins to compen-
sate the initial inhibition. As a result, this will cause no serious
harm to the cells to go to apoptosis but only a temporary inhi-
bition in the cell growth process.
If we investigate the behaviors of CPT and CPT delivered by
nanoparticles with different concentrations, CPT as we observed
in our previous study,37 becomes rapidly effective in the cell
growth inhibition even at the lowest concentration (0.1 mM) and
shorter time (48 h). However, in both concentrations the growth
inhibition is slower than free CPT confirming the slow release
feature of the nanoparticles supported by in vitro drug release
studies in different pHs. The release is even much slower in the
case of the nanoparticles having high drug loading contents.
This result might be explained by strong interactions between
CPT molecules and polymer chains because CPT molecules can
interact with each other more freely due to presence of fewer
polymer chains to interfere with this process. In lower loading
rates, CPT molecules can be evenly distributed in the polymer
matrix; not unlike dissolution. Upon cell internalization, these
matrices interact with hydrophobic membrane structures (endo-
somes) and CPT molecules can easily diffuse into these mem-
branes to show activity in the cell. However, higher CPT content
can bring out the intrinsic solubility problem of hydrophobic
drugs. CPT molecules can easily form highly stable aggregates
via p-p stacking inside the sparsely packed matrix and their like-
lihood of interacting with cellular hydrophobic compartments
drops drastically. Therefore they show little to no cellular activ-
ity for a long time after cell internalization.
CPT-loaded P1NPs were analyzed by fluorescence microscopy
on Huh7 cells. The red emission of P1NPs is an evidence for
FIGURE 6 Percentage of cumulative release of CPT from NP1
at different pH. The release of drug molecules was monitored
using a UV-Vis spectrophotometer (1:10 loading ratio of CPT/
P1NP). [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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an efficient cellular internalization. Nuclei were stained with
blue emitting Hoechst dye. The image of cells treated with
P1NP-A-CPT (with CPT concentration of 0.1 mM) taken after
24 h incubation show the perinuclear accumulation of red-
emitting nanoparticles (Supporting Information Fig. S21).
In the light of similar experiments in the literature12,24–26 we
suggest that NPs and the drug-loaded NPs might be internal-
ized by cells through endocytosis and enriched in intracellular
compartments, e.g., cytosolic vesicles and/or endosomes/lyso-
somes; however, further studies are needed for understanding
whether they are differentially targeted into compartments.
CONCLUSIONS
We have reported the preparation of pH-sensitive, near-
infrared emitting water dispersible conjugated polymer
nanoparticles. The nanoparticle dispersions are stable in
water over a month without forming any aggregates as
well as stable in various biological media. These nano-
particles could be loaded with hydrophobic anticancer
drugs with high loading efficiency for drug delivery and
cellular imaging. The results indicate that these nanopar-
ticles are promising as vehicles for image-guided, pH-
triggered release of anticancer drugs. Currently the work
regarding in vivo applications of this system is
underway.
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FIGURE 7 Real-time growth inhibitory effect of loaded and blank P1NPs with camptothecin on the human liver (Huh7) cancer cell
line were determined by RT-CES. The full profiles of the CPT, P1NP, P1NP-A-CPT and P1NP-B-CPT exposed cells over 144 h dura-
tion. The concentrations are based on CPT concentrations but in brackets the concentrations of nanoparticles were also given.
(0.1, 02, 04 mM CPT concentrations for 1:62 CPT/NP ratios correspond to 6.2, 12.4, 24.8 mM NP and for 1:10.4 CPT/NP ratios, 1.04,
2.08, 4.16 mM NP concentrations, respectively). The experiments were conducted in triplicate. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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